Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMC 2566677)

Published in Bull World Health Organ on November 01, 2001

Authors

N Aït-Khaled1, D Enarson, J Bousquet

Author Affiliations

1: International Union Against Tuberculosis and Lung Disease, Asthma Division, Paris, France. Naitkhaled@iuatld.org

Associated clinical trials:

Effectiveness of Low-dose Theophylline for the Management of Biomass-associated COPD in Uganda | NCT03984188

Articles citing this

The burden of non communicable diseases in developing countries. Int J Equity Health (2005) 4.61

Relationship between African dust carried in the Atlantic trade winds and surges in pediatric asthma attendances in the Caribbean. Int J Biometeorol (2008) 1.58

Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal (2011) 1.54

The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis (2016) 1.41

Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment. J Immunol (2009) 1.33

The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med (2009) 1.08

An estimate of asthma prevalence in Africa: a systematic analysis. Croat Med J (2013) 0.99

Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis (2007) 0.94

Prevalence of respiratory disease and associated factors in an urban area of delhi. Indian J Community Med (2008) 0.93

Isoforms of vitamin E differentially regulate inflammation. Endocr Metab Immune Disord Drug Targets (2010) 0.93

Heavy burden of non-communicable diseases at early age and gender disparities in an adult population of Burkina Faso: World Health Survey. BMC Public Health (2012) 0.91

Burden of Chronic Respiratory Diseases (CRD) in Middle East and North Africa (MENA). World Allergy Organ J (2011) 0.88

Isoforms of Vitamin E Differentially Regulate PKC α and Inflammation: A Review. J Clin Cell Immunol (2013) 0.87

The proportion of asthma and patterns of asthma medications prescriptions among adult patients in the chest, accident and emergency units of a tertiary health care facility in Uganda. Afr Health Sci (2012) 0.86

Chronic respiratory disease among the elderly in South Africa: any association with proximity to mine dumps? Environ Health (2015) 0.84

Trends in the use of antiasthmatic medications in Morocco (1999-2010). Springerplus (2013) 0.83

Asthma self-management: a study in an emergency room of a chest hospital in delhi, India. South Med Rev (2012) 0.79

Air Quality and Respiratory Health among Adolescents from the United Arab Emirates. J Environ Public Health (2015) 0.75

European Non-Communicable Respiratory Disease Research, 2002-13: Bibliometric Study of Outputs and Funding. PLoS One (2016) 0.75

Smoking prevalence and attitudes regarding its control among health professional students in South-Western Nigeria. Ann Med Health Sci Res (2013) 0.75

Chronic respiratory symptoms and associated factors among cement factory workers in Dejen town, Amhara regional state, Ethiopia, 2015. Multidiscip Respir Med (2016) 0.75

Spirometry in Asthma Care: A Review of the Trends and Challenges in Pediatric Practice. Clin Med Insights Pediatr (2017) 0.75

Effects of a self-management education program on self-efficacy in patients with COPD: a mixed-methods sequential explanatory designed study. Int J Chron Obstruct Pulmon Dis (2017) 0.75

Articles by these authors

(truncated to the top 100)

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

Tuberculosis in immigrants to Canada. A study of present-day patterns in relation to immigration trends and birthplace. Am Rev Respir Dis (1979) 2.90

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13

Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08

Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91

Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84

Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82

Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy (2007) 1.75

Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75

GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72

Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72

Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71

A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70

Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69

Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68

Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68

Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67

Chloroplast and nuclear gene sequences indicate late Pennsylvanian time for the last common ancestor of extant seed plants. Proc Natl Acad Sci U S A (1994) 1.66

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy (2007) 1.63

Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy (2004) 1.61

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy (2005) 1.59

Molecular evolution of angiosperm mitochondrial introns and exons. Proc Natl Acad Sci U S A (1997) 1.56

Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med (1997) 1.54

[Smoking habits, attitudes and knowledges of medical students of Medicine, Pharmacy and Odonto-Stomatology's Faculty of Dakar, Senegal]. Rev Mal Respir (2003) 1.54

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy (2013) 1.54

Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy (2009) 1.53

Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53

[Results in pulmonary tuberculosis patients under various treatment program conditions]. Bull Int Union Tuberc (1978) 1.51

GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50

Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol (1991) 1.50

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.50

Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr (1997) 1.49

Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45

Epidemiology of cypress pollen allergy in Montpellier. J Investig Allergol Clin Immunol (2012) 1.45

Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. J Rheumatol (1997) 1.43

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42

Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy. J Allergy Clin Immunol (1980) 1.40

Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol (1993) 1.39

[Non-communicable chronic diseases, a global public health priority recognized by the United Nations]. Presse Med (2011) 1.39

[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal]. Rev Mal Respir (2004) 1.39

[Gastric site of epidermoid carcinoma]. Presse Med (1997) 1.39

Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol (2000) 1.38

Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy (2007) 1.35

Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35

A follow-up study of the grain elevator workers in the Port of Vancouver. Arch Environ Health (1981) 1.35

Host factors affecting longitudinal decline in lung spirometry among grain elevator workers. Chest (1984) 1.35

The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33

Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30

Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy (2011) 1.29

IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol (1998) 1.28

GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy (2010) 1.28

Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med (1996) 1.28

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol (1997) 1.27

HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis (1993) 1.26

Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis (1992) 1.26

Tuberculosis in British Columbia among immigrants from five Asian countries, 1982-85. Tubercle (1989) 1.26

Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol (1999) 1.25

Asthma mortality in France. J Allergy Clin Immunol (1987) 1.25

Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25

EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-- descriptive characteristics. Clin Exp Allergy (1999) 1.23

RAPDs as an aid to evaluate the genetic integrity of somatic embryogenesis-derived populations of Picea mariana (Mill.) B.S.P. Theor Appl Genet (1993) 1.22

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy (2014) 1.22

[First validation of the French version of the Gastrointestinal Quality of Life Index (GIQLI)]. Gastroenterol Clin Biol (1999) 1.21

Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med (1997) 1.21

Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy (2008) 1.20

Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol (2000) 1.20

Relation of grading of sputum smears with clinical features of tuberculosis patients in routine practice in Sudan. Int J Tuberc Lung Dis (2002) 1.17

Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am Rev Respir Dis (1993) 1.17

Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy (2003) 1.17

Airway remodelling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol (2001) 1.16

The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy (2009) 1.15

Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol (1987) 1.14

Rupatadine in allergic rhinitis and chronic urticaria. Allergy (2008) 1.13

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy (2012) 1.13

Complete congruence between gene diversity estimates derived from genotypic data at enzyme and random amplified polymorphic DNA loci in black spruce. Proc Natl Acad Sci U S A (1995) 1.13

The prevalence of symptoms associated with pulmonary tuberculosis in randomly selected children from a high burden community. Arch Dis Child (2005) 1.11

Genetic diversity and phylogenetic relationships between birches and alders using ITS, 18S rRNA and rbcL gene sequences. Mol Phylogenet Evol (1993) 1.11

Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD. Thorax (2003) 1.10

Evolution of the mitochondrial rps3 intron in perennial and annual angiosperms and homology to nad5 intron 1. Mol Biol Evol (1999) 1.09

Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J Immunol (2000) 1.09

Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers. Cancer Res (1989) 1.09